Cargando…
Aberrant rhythmic expression of cryptochrome2 regulates the radiosensitivity of rat gliomas
In this study, we investigated the role of the clock regulatory protein cryptochrome 2 (Cry2) in determining the radiosensitivity of C6 glioma cells in a rat model. We observed that Cry2 mRNA and protein levels showed aberrant rhythmic periodicity of 8 h in glioma tissues, compared to 24 h in normal...
Autores principales: | Fan, Wang, Caiyan, Li, Ling, Zhu, Jiayun, Zhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652816/ https://www.ncbi.nlm.nih.gov/pubmed/29100427 http://dx.doi.org/10.18632/oncotarget.20835 |
Ejemplares similares
-
CRYPTOCHROMES confer robustness, not rhythmicity, to circadian timekeeping
por: Putker, Marrit, et al.
Publicado: (2021) -
Cryptochromes mediate rhythmic repression of the glucocorticoid receptor
por: Lamia, Katja A., et al.
Publicado: (2011) -
AUF1 contributes to Cryptochrome1 mRNA degradation and rhythmic translation
por: Lee, Kyung-Ha, et al.
Publicado: (2014) -
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair
por: Shafi, Ayesha A., et al.
Publicado: (2021) -
BMAL1 may be involved in angiogenesis and peritumoral cerebral edema of human glioma by regulating VEGF and ANG2
por: Wang, Fan, et al.
Publicado: (2021)